Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | AZN | AMGN | GILD | VRTX |
| Company | Genmab A/S ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 31.34 | 91.18 | 321.82 | 121.07 | 442.55 |
| High | 31.58 | 91.45 | 323.00 | 122.25 | 448.28 |
| Low | 31.14 | 90.16 | 316.71 | 119.56 | 438.61 |
| Latest | 31.29 | 90.36 | 317.24 | 119.79 | 439.84 |
| Change | -0.65 | -0.92 | -3.99 | -1.40 | -2.20 |
| % Change | -2.04% | -1.01% | -1.24% | -1.16% | -0.50% |
| Volume | 447,068 | 1,456,215 | 632,519 | 970,995 | 218,809 |
| 20-Day Average Volume | 1,317,671 | 5,341,562 | 2,828,718 | 6,803,729 | 1,356,238 |
| Previous Close | 31.94 | 91.28 | 321.23 | 121.19 | 442.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.07 | 90.32 | 337.26 | 124.56 | 435.53 |
| 20-Day Raw Stochastic | 62.66% | 47.46% | 4.60% | 13.71% | 48.03% |
| 20-Day Relative Strength | 54.99 | 58.84 | 47.54 | 45.96 | 54.87 |
| Weighted Alpha | +62.32 | +39.14 | +17.72 | +27.12 | -2.24 |
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 56% Buy | 88% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.34% since 12/02/25 | +0.31% since 12/02/25 | -6.00% since 12/02/25 | -3.18% since 12/02/25 | +1.48% since 12/02/25 |
| Low | 31.14 on 12/09/25 | 89.67 on 12/08/25 | 316.71 on 12/09/25 | 119.64 on 12/09/25 | 438.90 on 12/09/25 |
| High | 32.41 on 12/04/25 | 91.43 on 12/09/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +9.16% since 11/07/25 | +6.94% since 11/07/25 | -0.66% since 11/07/25 | +0.95% since 11/07/25 | +7.35% since 11/07/25 |
| Low | 28.89 on 11/10/25 | 85.85 on 11/10/25 | 316.71 on 12/09/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 32.48 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +12.41% since 09/09/25 | +11.36% since 09/09/25 | +13.61% since 09/09/25 | +3.64% since 09/09/25 | +10.87% since 09/09/25 |
| Low | 27.58 on 09/10/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 33.65 on 10/16/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +40.61% since 06/09/25 | +23.89% since 06/09/25 | +9.69% since 06/09/25 | +6.17% since 06/09/25 | -1.48% since 06/09/25 |
| Low | 20.23 on 07/03/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 33.65 on 10/16/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,517,744 | 283,098,176 | 172,976,256 | 150,358,016 | 112,153,952 |
| Shares Outstanding, K | 642,384 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 3,121,270,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 1,137,380,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,022,000,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 401,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.90 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 15.33 | 19.73 | 15.08 | 14.80 | 29.75 |